Proteome Sciences plc

Proteome Sciences plc is a leading biotechnology research company dedicated to advancing drug discovery, development, and biomarker identification through specialized contract proteomics services. Leveraging proprietary workflows, Proteome Sciences plc delivers optimal analysis of tissues, cells, and body fluids, ensuring high-quality results and actionable insights. The company's state-of-the-art research facility in Frankfurt, certified to ISO 9001:2015 and GCLP, reflects a commitment to excellence and precision in every project.

Proteome Sciences plc offers comprehensive proteomics services utilizing SysQuant® and TMT®MS2, unbiased methods for identifying new targets and defining biological activity mechanisms. With Super-Depletion and TMTcalibrator™, Proteome Sciences plc accesses over 8,500 circulating plasma proteins, enabling the discovery of disease-related biomarkers. The company's expertise extends to targeted assay development using mass spectrometry, providing high-sensitivity biomarker analyses where standard ELISA assays are not available. Proteome Sciences plc is located at Coveham House, Downside Bridge Road, Cobham, KT11 3EP, GB, and Altenhöferallee 3, Frankfurt-am-Main, 60438, DE.

With a proven track record in the life sciences sector, Proteome Sciences plc collaborates with pharmaceutical and diagnostics companies, offering protein biomarker services and a wealth of experience in human and animal sample types, including blood plasma, CSF, solid tissues, and cell culture material. Proteome Sciences plc has also discovered and patented numerous novel protein biomarkers for diagnosing, prognosing, and treating key human diseases, including neurodegenerative disorders, cancer, and stroke. We invite the management team of Proteome Sciences plc to create a customized and exclusive company showcase and product listing on our platform to further enhance their market presence and commercial development.